Hayek Medical, a division of United Hayek Industries, specializes in the design, manufacture and sale of non-invasive respiratory devices, in particular using a new and patented method of ventilation to achieve what is known as Biphasic Cuirass Ventilation (BCV). We are the world leader in this unique method of ventilation.
BCV has been proven to be extremely effective for a wide variety of patient groups: Neuromuscular, COPD, Cystic Fibrosis, and ARDS patients amongst many others. Due to the ability of BCV to effectively recruit the dorsal regions of the lungs and improve V/Q mismatch, it has proven to be a good alternative to proning for some patients during the COVID-19 pandemic.
BCV can be applied in the hospital to avoid intubation for patients in respiratory failure or to expedite weaning from positive pressure ventilation. It is also an excellent means to manage chronic respiratory failure at home to prevent frequent readmissions and promote a better quality of life. BCV minimizes risks and complications, leading to significantly better patient and financial outcomes.
Please come visit us to find out how and to try on this unique mode of extra-thoracic noninvasive ventilation!